Levi & Korsinsky, LLP announces that an MDT class action lawsuit has been filed on behalf of investors who purchased Medtronic plc (MDT) securities between June 8, 2019, and May 25, 2022. For more on the MDT Lawsuit please contact us today.

According to the Medtronic plc lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Medtronic’s product quality control systems were inadequate; (2) Medtronic had failed to comply with numerous regulations regarding risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events; (3) these failures increased the risk of regulatory investigation and action; (4) as a result of the Company’s misconduct, the U.S. Food and Drug Administration would delay the approval of additional Medtronic MiniMed devices, including the MiniMed 780G; (5) these delays in product approvals, as well as the Company’s need to improve its quality control systems, would negatively affect the Company’s financial performance and cause Medtronic to fall further behind its competitors; and (6) as a result of the foregoing, defendant’s statements about the Company’s business, operations, and prospects lacked a reasonable basis.

TO LEARN MORE ABOUT THE MDT CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Medtronic plc you have until November 7, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com